IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS Aggregate Spend Compliance Services, a comprehensive set of solutions to help pharmaceutical and medical device companies comply with the growing number of federal and state transparency and marketing disclosure laws in the U.S., known as “aggregate spend” reporting regulations. IMS’s suite of information and advisory services enables clients to implement a fully integrated monitoring and reporting compliance infrastructure – providing an accurate view of their promotional spend associated with healthcare professionals. The services leverage the best-in-class compliance application platform of R-Squared Services & Solutions, a leading developer of evidence-based compliance solutions for the healthcare and life sciences industries.
“Tracking and monitoring the total promotional spend to healthcare providers is a difficult operational challenge that many life sciences companies struggle with daily”
“Tracking and monitoring the total promotional spend to healthcare providers is a difficult operational challenge that many life sciences companies struggle with daily,” said Don Otterbein, IMS general manager, Business Transformation Services. “IMS Aggregate Spend Compliance Services enable our clients to align and manage professional and organizational information across disparate systems and functions – effectively addressing the complexities in data capture, standardization and integration. Our solution also includes a flexible and scalable reporting system, allowing for quick response to evolving regulations and reporting requirements.”